|Printable version||E-mail this to a friend|
Cancer Research UK - Two million people will be diagnosed with cancer during the next parliament
Cancer Research UK expects around two million people to be diagnosed with cancer in the UK during the length of the next parliament according to new figures released yesterday
The charity estimates that the yearly number of those given a cancer diagnosis will exceed 400,000 by 2020, climbing from an annual figure of around 357,000 in 2014.
The figures, calculated for 2017 to 2021, reveal the increasing number of people who will need to be diagnosed, treated and cared for by an already struggling health service.
Diagnostic services have not kept up with demand as the number of patients waiting too long to start treatment after being urgently referred for tests has continued to grow. In England, the target of 85 per cent of patients starting treatment within 62 days has not been met for three years.
More people than ever are being diagnosed with and treated for cancer, but if the NHS cannot meet growing demand, more people are at risk of having to wait longer for treatment, or receiving a late diagnosis.
In 2015 a new Cancer Strategy for England was published which outlined clear steps that needed to be taken if the health service is to provide patients with cancer care equal to the best in the world.
Cancer Research UK is urging all parties to renew commitment to delivering the Cancer Strategy.
Sarah Woolnough, Cancer Research UK’s executive director of policy and information, said: “Tackling cancer and achieving world class outcomes for people across the country must be a priority for the next Government. We know that action must be taken and the Cancer Strategy provides a plan for how to do this – but it can only be achieved by ensuring the NHS has the resources to prevent, diagnose and treat more people.”
For media enquiries please contact the Cancer Research UK press office on +44 203 469 8300 or, out-of-hours, the duty press officer on +44 7050 264 059.
Notes to Editor
* In 2014 around 357,000 people were diagnosed with cancer in the UK. Projected cancer cases over the next five years show:
Health is a devolved issue. This General Election will see the public voting for the next UK Government, which is responsible for the NHS in England. The administrations Scotland, Wales and Northern Ireland have responsibility for their own health systems.
Calculated by the Statistical Information Team at Cancer Research UK, 2016. Based on the total number of projected new cancer cases (ICD10 C00-C97,excl C44) between 2017-2021, from Cancer incidence and mortality projections in the UK until 2035. Smittenaar et al, 2016. https://www.ncbi.nlm.nih.gov/pubmed/27727232 (link is external)
Read more about Cancer Research UK’s four priority areas for the 2017 General Election: http://scienceblog.cancerresearchuk.org/2017/04/28/general-election-2017-4-things-we-want-political-parties-to-focus-on/
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.